Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Acute Pancreatitis | Research

Risk factors for diabetic ketoacidosis in acute pancreatitis patients with type 2 diabetes

Authors: Lin Li, Linzhen Li

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background and purpose

In cinical, some acute pancreatitis patients with diabetes may have diabetic ketoacidosis (DKA). However, the risk factors for DKA in these patients remain unclear. The purpose of this study is to analyze the risk factors for DKA in acute pancreatitis patients with type 2 diabetes.

Patients and methods

Twenty-five patients were included in this prospective single-centre study to analyze the incidence and risk factors for DKA in acute pancreatitis patients with type 2 diabetes.

Results

Seven of the twenty-five patients (28%) developed DKA within 48 h of admission. According to whether they had DKA, the twenty-five AP patients were divided into DKA group and non-DKA group. There were significant differences in age (P = 0.014), BMI (P = 0.034), poor previous blood glucose control (P < 0.001) and uric acid concentration (P = 0.041), but no statistically significant differences in sex (P = 0.597), number of drinkers (P = 0.407), number of smokers (P = 1.000), triglyceride level (P = 0.389) and total cholesterol concentration (P = 0.534) between the two groups. In both groups, 1 patients had severe pancreatitis, and the difference was no statistically significant (P = 0.490).

Conclusions

The incidence of DKA in AP patients with diabetes is high. Age, BMI, worse glycemic control and uric acid concentration may be predictors of DKA in AP patients with diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Matta B, Gougol A, Gao X, et al. Worldwide Variations in demographics, management, and outcomes of Acute Pancreatitis. Clin Gastroenterol Hepatol. 2020;18(7):1567–1575e2.CrossRefPubMed Matta B, Gougol A, Gao X, et al. Worldwide Variations in demographics, management, and outcomes of Acute Pancreatitis. Clin Gastroenterol Hepatol. 2020;18(7):1567–1575e2.CrossRefPubMed
2.
go back to reference Lankisch PG, Assmus C, Lehnick D, Maisonneuve P, Lowenfels AB. Acute pancreatitis: does gender matter. Dig Dis Sci. 2001;46(11):2470–4.CrossRefPubMed Lankisch PG, Assmus C, Lehnick D, Maisonneuve P, Lowenfels AB. Acute pancreatitis: does gender matter. Dig Dis Sci. 2001;46(11):2470–4.CrossRefPubMed
4.
go back to reference Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.CrossRefPubMed Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.CrossRefPubMed
5.
go back to reference IAP/APA evidence. -based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4 Suppl 2):e1–15. IAP/APA evidence. -based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4 Suppl 2):e1–15.
6.
go back to reference Dhatariya KK. Defining and characterising diabetic ketoacidosis in adults. Diabetes Res Clin Pract. 2019;155:107797.CrossRefPubMed Dhatariya KK. Defining and characterising diabetic ketoacidosis in adults. Diabetes Res Clin Pract. 2019;155:107797.CrossRefPubMed
7.
go back to reference Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020;6(1):40.CrossRefPubMed Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020;6(1):40.CrossRefPubMed
8.
go back to reference Kosekli MA, Herek Ö, Ozmen Ö, Sahinduran S. Ameliorative effect of certolizumab on experimentally induced acute necrotic pancreatitis in rats. Rev Assoc Med Bras (1992). 2019. 65(2): 204–210. Kosekli MA, Herek Ö, Ozmen Ö, Sahinduran S. Ameliorative effect of certolizumab on experimentally induced acute necrotic pancreatitis in rats. Rev Assoc Med Bras (1992). 2019. 65(2): 204–210.
9.
go back to reference Hughes CB, Grewal HP, Gaber LW, et al. Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg. 1996;171(2):274–80.CrossRefPubMed Hughes CB, Grewal HP, Gaber LW, et al. Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am J Surg. 1996;171(2):274–80.CrossRefPubMed
10.
go back to reference Shanmugam N, Reddy MA, Guha M, Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes. 2003;52(5):1256–64.CrossRefPubMed Shanmugam N, Reddy MA, Guha M, Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes. 2003;52(5):1256–64.CrossRefPubMed
11.
go back to reference Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992;130(1):43–52.CrossRefPubMed Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992;130(1):43–52.CrossRefPubMed
12.
go back to reference Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–15.CrossRefPubMed Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400–15.CrossRefPubMed
13.
go back to reference Li J, Chen J, Tang W. The consensus of integrative diagnosis and treatment of acute pancreatitis-2017. J Evid Based Med. 2019;12(1):76–88.CrossRefPubMed Li J, Chen J, Tang W. The consensus of integrative diagnosis and treatment of acute pancreatitis-2017. J Evid Based Med. 2019;12(1):76–88.CrossRefPubMed
14.
go back to reference Dabelea D, Rewers A, Stafford JM, et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938–45.CrossRefPubMedPubMedCentral Dabelea D, Rewers A, Stafford JM, et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938–45.CrossRefPubMedPubMedCentral
15.
go back to reference Fu Y, Liu X, Cui B, Wang C, Liu Z, Zhao B. Clinical characteristics of Concomitant Diabetic Ketoacidosis in type 2 diabetes patients with Acute Pancreatitis. Diabetes Metab Syndr Obes. 2022;15:111–9.CrossRefPubMedPubMedCentral Fu Y, Liu X, Cui B, Wang C, Liu Z, Zhao B. Clinical characteristics of Concomitant Diabetic Ketoacidosis in type 2 diabetes patients with Acute Pancreatitis. Diabetes Metab Syndr Obes. 2022;15:111–9.CrossRefPubMedPubMedCentral
16.
go back to reference Del Degan S, Dubé F, Gagnon C, Boulet G. Risk factors for recurrent Diabetic ketoacidosis in adults with type 1 diabetes. Can J Diabetes. 2019;43(7):472–476e1.CrossRefPubMed Del Degan S, Dubé F, Gagnon C, Boulet G. Risk factors for recurrent Diabetic ketoacidosis in adults with type 1 diabetes. Can J Diabetes. 2019;43(7):472–476e1.CrossRefPubMed
17.
go back to reference Everett E, Mathioudakis N. Association of Area Deprivation and Diabetic Ketoacidosis Readmissions: comparative risk analysis of adults vs children with type 1 diabetes. J Clin Endocrinol Metab. 2019;104(8):3473–80.CrossRefPubMedPubMedCentral Everett E, Mathioudakis N. Association of Area Deprivation and Diabetic Ketoacidosis Readmissions: comparative risk analysis of adults vs children with type 1 diabetes. J Clin Endocrinol Metab. 2019;104(8):3473–80.CrossRefPubMedPubMedCentral
18.
go back to reference Everett E, Mathioudakis NN. Association of socioeconomic status and DKA readmission in adults with type 1 diabetes: analysis of the US National Readmission Database. BMJ Open Diabetes Res Care. 2019;7(1):e000621.CrossRefPubMedPubMedCentral Everett E, Mathioudakis NN. Association of socioeconomic status and DKA readmission in adults with type 1 diabetes: analysis of the US National Readmission Database. BMJ Open Diabetes Res Care. 2019;7(1):e000621.CrossRefPubMedPubMedCentral
19.
go back to reference Yan JH, Yang DZ, Deng HR, Li J, Weng JP. [Incidence and related risk factors of diabetic ketoacidosis in Guangdong type 1 diabetics]. Zhonghua Yi Xue Za Zhi. 2013;93(12):897–901.PubMed Yan JH, Yang DZ, Deng HR, Li J, Weng JP. [Incidence and related risk factors of diabetic ketoacidosis in Guangdong type 1 diabetics]. Zhonghua Yi Xue Za Zhi. 2013;93(12):897–901.PubMed
20.
go back to reference Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003;425(6957):516–21.CrossRefPubMed Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003;425(6957):516–21.CrossRefPubMed
21.
go back to reference Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134(3):297–302.CrossRefPubMed Aktas G, Khalid A, Kurtkulagi O, et al. Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study. Postgrad Med. 2022;134(3):297–302.CrossRefPubMed
22.
go back to reference van der Schaft N, Brahimaj A, Wen KX, Franco OH, Dehghan A. The association between serum uric acid and the incidence of prediabetes and type 2 diabetes mellitus: the Rotterdam Study. PLoS ONE. 2017;12(6):e0179482.CrossRefPubMedPubMedCentral van der Schaft N, Brahimaj A, Wen KX, Franco OH, Dehghan A. The association between serum uric acid and the incidence of prediabetes and type 2 diabetes mellitus: the Rotterdam Study. PLoS ONE. 2017;12(6):e0179482.CrossRefPubMedPubMedCentral
23.
go back to reference Ali N, Perveen R, Rahman S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on bangladeshi adults. PLoS ONE. 2018;13(11):e0206850.CrossRefPubMedPubMedCentral Ali N, Perveen R, Rahman S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on bangladeshi adults. PLoS ONE. 2018;13(11):e0206850.CrossRefPubMedPubMedCentral
25.
go back to reference Kosekli MA, Kurtkulagii O, Kahveci G et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras (1992). 2021. 67(4): 549–554. Kosekli MA, Kurtkulagii O, Kahveci G et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras (1992). 2021. 67(4): 549–554.
26.
go back to reference Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098–102.CrossRefPubMed Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098–102.CrossRefPubMed
27.
go back to reference Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019;65(1):9–15.CrossRefPubMed Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019;65(1):9–15.CrossRefPubMed
Metadata
Title
Risk factors for diabetic ketoacidosis in acute pancreatitis patients with type 2 diabetes
Authors
Lin Li
Linzhen Li
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02869-2

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.